Cover Image

FDA user fee agreements: advancing medical product regulation and innovation for the benefit of patients, FDA center directors : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventeenth Congress, second session on examining Food and Drug Administration user fee agreements, focusing on advancing medical product regulation and innovation for the benefit of patients and Food and Drug Administration center directors, April 26, 2022.

Bibliographic Details
Corporate Author:	United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions (Author)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. Government Publishing Office, 2023.
Series:	S. hrg. ; 117-395
Subjects:	User charges > United States. Drug approval > United States. Medical supplies > Certification > United States. Legislative hearings.
Online Access:	https://purl.fdlp.gov/GPO/gpo220213

Similar Items

FDA user fee agreements : strengthening FDA and the medical products industry for the benefit of patients : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, second session ... March 29, 2012.
Published: (2014)

FDA user fee agreements : improving medical product regulation and innovation for patients : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, first session on ... March 21, 2017.
Published: (2018)

FDA User Fee Agreements : Improving Medical Product Regulation and Innovation for Patients.
Published: (2017)

FDA User Fee Agreements : Strengthening FDA and the Medical Products Industry for the Benefit of Patients.
Published: (2012)

FDA user fees : advancing public health : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session ... July 28, 2011.
Published: (2014)

Guidance for industry and FDA staff : application user fees for combination products.
Published: (2005)

User fees and refunds for premarket approval applications.
Published: (2009)

FDA User Fees 2012 : How Innovation Helps Patients and Jobs.
Published: (2012)

FDA User Fees : Advancing Public Health.
Published: (2011)

Animal drug user fee agreements : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, first session, on examining animal drug user fee agreements, focusing on advancing animal health for the public health, February 27, 2013.
Published: (2014)

FDA user fees 2012 : how innovation helps patients and jobs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, April 18, 2012.
Published: (2013)

FDA human medical product user fee programs: in brief /
by: Bodie, Agata, et al.
Published: (2021)

Examining FDA's Medical Device User Fee Program.
Published: (2017)

User fees and refunds for premarket approval applications.
Published: (2003)

Examining FDA's Prescription Drug User Fee Program.
Published: (2017)

Guidance for FDA reviews and sponsors : content and review of chemistry, manufacturing, and control (CMC) information for human gene therapy investigational new drug applications (INDs).
Published: (2008)

FDA user fees 2012 : issues related to accelerated approval, medical gas, antibiotic development, and downstream pharmaceutical supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, March 8, 2012.
Published: (2013)

An overview of FDA regulated products : from drugs and cosmetics to food and tobacco /
Published: (2018)

Proposed FDA user fee acts : Generic Drug User Fee Amendments of 2012 (GDUFA) and Biosimilar User Fee Act of 2012 (BSUFA) /
by: Thaul, Susan, et al.
Published: (2019)

Examining FDA's Generic Drug and Biosimilar User Fee Programs.
Published: (2017)

FDA's drug review process and the package label : strategies for writing successful FDA submissions /
by: Brody, Tom
Published: (2017)

Amending the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs : report (to accompany H.R. 1407) (including cost estimate of the Congressional Budget Office).
Published: (2013)

The FDA medical device user fee program : MDUFA IV reauthorization /
by: Johnson, Judith A. (Judith Ann), 1957-
Published: (2018)

Guidance for industry and FDA staff : how to write a request for designation (RFD).
Published: (2005)

Improving animal health : reauthorization of FDA animal drug user fees : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining improving animal health, focusing on reauthorization of Food and Drug Administration animal drug user fees, February 13, 2018.
Published: (2020)

FDA user fees and the regulation of drugs, biologics, and devices : comparative analysis of S. 3187 and H.R. 5651 /
by: Thaul, Susan
Published: (2018)

Committee prints on administration legislative proposals on the Animal Drug User Fee Act Amendments of 2008 and the Animal Generic Drug User Fee Act of 2008 : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, June 5, 2008.
Published: (2008)

Food and Drug Administration : effect of user fees on drug approval times, withdrawals, and other agency activities.
Published: (2002)

Animal Generic Drug User Fee Act of 2008 : report (to accompany H.R. 6433) (including cost estimate of the Congressional Budget Office).
Published: (2008)

Drugs and the FDA : safety, efficacy, and the public's trust /
by: Sekeres, Mikkael A.
Published: (2022)

Guidance for FDA reviews and sponsors : content and review of chemistry, manufacturing, and control (CMC) information for human somatic cell therapy investigational new drug applications (INDS).
Published: (2008)

The FDA medical device user fee program /
by: Johnson, Judith A. (Judith Ann), 1957-
Published: (2020)

Guidance for industry and FDA staff : submission and resolution of formal disputes regarding the timeliness of premarket review of a combination product.
Published: (2004)

Animal Drug User Fee Amendments of 2008 : report (to accompany H.R. 6432) (including cost estimate of the Congressional Budget Office).
Published: (2008)

Medical Device User Fees and User Fee Acts.
Published: (2008)

Medical Device User Fees and User Fee Acts.
Published: (2009)

Guidance for FDA staff and industry : marketed unapproved drugs, compliance policy guide.
Published: (2006)

Examining FDA's Prescription Drug User Fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
Published: (2018)

Preparing for FDA pre-approval inspections /
Published: (1999)